Stock Events

Merck 

$110.21
5788
-$0.06-0.05% Today

Statistics

Day High
110.3
Day Low
108.2
52W High
134.63
52W Low
99.14
Volume
8,362,955
Avg. Volume
9,451,857
Mkt Cap
300.25B
P/E Ratio
21.94
Dividend Yield
2.79%
Dividend
3.08

Upcoming

Dividends

2.79%Dividend Yield
10Y Growth
5.7%
5Y Growth
6.39%
3Y Growth
5.27%
1Y Growth
4.05%

Earnings

31OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
-2.19
-0.7
0.79
2.28
Expected EPS
1.742328
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MRK. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Analyst Ratings

138.14$Average Price Target
The highest estimate is $155.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy
71%
Hold
29%
Sell
0%

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Show more...
CEO
Employees
70000
Country
US
ISIN
US58933Y1055

Listings